Overview
A long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections.
Background
A long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections.
Indication
Sulfadoxine is used in combination with pyrimethamine for the treatment or prevention of malaria. It can also be used to treat various infections in livestock as well. Sulfadoxine and pyrimethamine is indicated for the treatment of Plasmodium falciparum malaria in those patients in whom chloroquine resistance is suspected.
Associated Conditions
- Malaria
- Malaria caused by Plasmodium falciparum
- Acute, uncomplicated Malaria caused by plasmodium falciparum
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/03/11 | Not Applicable | Not yet recruiting | |||
2024/07/26 | Phase 1 | Not yet recruiting | |||
2023/08/21 | Not Applicable | Completed | |||
2023/08/07 | Phase 4 | Completed | |||
2023/07/17 | Not Applicable | Recruiting | |||
2023/06/05 | N/A | Active, not recruiting | |||
2023/05/12 | N/A | Active, not recruiting | |||
2022/07/28 | Phase 4 | Active, not recruiting | |||
2022/07/25 | Phase 3 | Active, not recruiting | |||
2022/06/22 | Phase 3 | Active, not recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Sulfadoxine Tablets | 国药准字H51022024 | 化学药品 | 片剂 | 11/18/2020 | |
| Sulfadoxine Tablets | 国药准字H22026592 | 化学药品 | 片剂 | 5/22/2020 | |
| Sulfadoxine Tablets | 国药准字H37022340 | 化学药品 | 片剂 | 3/12/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||